enVVeno Medical Corp

5HJ

Company Profile

  • Business description

    enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

  • Contact

    70 Doppler
    IrvineCA92618
    USA

    T: +1 949 261-2900

    https://www.envveno.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    37

Stocks News & Analysis

stocks

ASX listed tariff play

Trump’s focus on US steel production may benefit this firm.
stocks

Ask the analyst: How reliant are Guzman shares on international growth?

A year on from Guzman’s IPO, I catch up with Johannes Faul to explore what is baked into GYG’s valuation.
stocks

Nvidia: Back in business in China; Raising fair value estimate

Nvidia is poised to become more dominant than ever as it is allowed to sell its key H20 GPUs in China.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,890.8074.400.84%
CAC 407,822.0099.911.29%
DAX 4024,370.93361.551.51%
Dow JONES (US)44,484.49229.710.52%
FTSE 1008,972.6446.090.52%
HKSE24,498.9518.81-0.08%
NASDAQ20,885.65155.160.75%
Nikkei 22539,901.19237.790.60%
NZX 50 Index12,905.41150.821.18%
S&P 5006,297.3633.660.54%
S&P/ASX 2008,639.0077.200.90%
SSE Composite Index3,516.8313.050.37%

Market Movers